Influence of the Proton Pump Inhibitor Lansoprazole on Distribution and Activity of Doxorubicin in Solid Tumors

Cancer Science - United States
doi 10.1111/cas.12756
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Proton Pump Inhibitor Lansoprazole, but Not Rabeprazole, the Increased Blood Concentrations of Calcineurin Inhibitors in Japanese Patients With Connective Tissue Diseases

Internal Medicine
Internal MedicineMedicine
2014English

Letter: Proton Pump Inhibitor Use and Risk of Fracture

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Proton Pump Inhibitor-Amoxicillin-Clarithromycin Versus Proton Pump Inhibitor-Amoxicillin-Metronidazole as First-Line Helicobacter Pylori Eradication Therapy

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2012English

Hypomagnesemia Associated With a Proton Pump Inhibitor

Internal Medicine
Internal MedicineMedicine
2012English

An Overview on Formulations and Their Evaluation of Esomeparozle – A Proton Pump Inhibitor

Indian Research Journal of Pharmacy and Science
2019English

Pleotropic Effects of Proton Pump Inhibitors Guest Editor: Yuji Naito Gastric Epithelial Cell Modality and Proton Pump Inhibitor

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2008English

Proton Pump Inhibitor-Responsive Oesophageal Eosinophilia and Eosinophilic Oesophagitis

Current Opinion in Gastroenterology
Gastroenterology
2015English

Regression of Barrett’s Esophagus With Proton Pump Inhibitor Therapy

Progress of Digestive Endoscopy
2008English

Influence of Geant4 Parameters on Proton Dose Distribution

International Journal of Cancer Therapy and Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy